BioStem Technologies, Inc. (BSEM) earnings
BSEM earnings moved a median of +0.17% by the close. Quarterly and annual BSEM reports and results, each read against the price at its own news timestamp. Back to the BSEM overview →
19 measured BSEM earnings events.
Where these BSEM earnings landedvs 19 measured BSEM earnings reactions
| Middle 50% of BSEM earnings reactions | -3.66% to +4.99% |
|---|---|
| Median reaction (to close) | +0.17% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 BSEM earnings events with a measured close landed between -3.66% and +4.99%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| BioStem Technologies Reports Second Quarter 2026 Financial Results | Press release | +27.39% | +34.78% | |
| Form 10-Q BioStem Technologies, For: Jun 30 | SEC filing · Form 10-Q | +27.39% | +34.78% | |
| BioStem Technologies to Host Second Quarter 2026 Financial Results Conference Call on August 12, 2026 | Press release | -0.15% | -2.15% | |
| BioStem Technologies Reports First Quarter 2026 Financial Results | Press release | -10.62% | -4.42% | |
| BioStem Technologies to Host First Quarter 2026 Financial Results Conference Call on May 14, 2026 | Press release | -1.11% | -1.11% | |
| BioStem Technologies to Host Third Quarter 2025 Financial Results Conference Call on November 13, 2025 | Press release | +7.42% | +7.66% | |
| BioStem Technologies Reports Preliminary Second Quarter 2025 Financial Results | Press release | -23.44% | -14.04% | |
| BioStem Technologies to Host Second Quarter 2025 Financial Results Conference Call on August 14, 2025 | Press release | — | +0.17% | |
| BioStem Technologies Reports Preliminary First Quarter 2025 Operating and Financial Results | Press release | -15.75% | -15.01% | |
| BioStem Technologies to Host First Quarter 2025 Financial Results Conference Call on May 12, 2025 | Press release | -3.65% | -2.89% | |
| BioStem Technologies Announces Extension to File 2024 Annual Report with OTC | Press release | -8.33% | +5.13% | |
| BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million | Press release | +0.12% | -2.38% | |
| BioStem Technologies to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 | Press release | -1.26% | +0.33% | |
| BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million | Press release | -0.15% | +1.35% | |
| BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024 | Press release | -5.47% | -8.36% | |
| BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024 | Press release | +3.35% | +7.51% | |
| BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024 | Press release | +1.47% | +1.37% | |
| BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results | Press release | +0.00% | +4.85% | |
| BioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023 | Press release | +1.51% | -6.36% |
Keep exploring
More BSEM: analyst actions → · SEC filings → · BSEM overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Fonar Corporation (FONR) | 137 | 0.00% | 34% |
| Biomerica, Inc. (BMRA) | 135 | 0.00% | 49% |
| Amedisys Inc (AMED) | 134 | -0.01% | 44% |
| ISODIOL INTERNATIONAL INC (ISOLF) | 134 | +0.20% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.